MINNEAPOLIS, July 20 /PRNewswire-FirstCall/ -- CNS, Inc. , the Breathe Right(R) company, today announced that Kevin McKenna has joined the company in the newly created position of vice president of International, effective immediately.
“Kevin brings 25 years of experience in international sales, management and business development for growth-oriented companies,” said Marti Morfitt, president and chief executive officer of CNS, Inc. “We are very pleased that he will lead our international sales efforts.”
Over the past six months, McKenna has consulted with CNS on strategic recommendations and execution of international initiatives, with a focus on the areas of new market development and European growth.
Previously, McKenna held several executive positions at General Mills in its $2 billion Bakeries and Foodservice Division. Most recently, he served as vice president and general manager of bakery sales and marketing in the United States and Canada, a $400 million business. Prior to that, he held positions as vice president and general manager of international bakeries and foodservice, vice president of strategy and business development and, before that, as director of corporate business development.
In addition, McKenna previously served as director of finance with The Liggett Group in New York. He also held a variety of sales and marketing positions in Rome, Italy, while employed by Unisys Corporation.
“Over the past several years, CNS has begun to establish a solid presence in key international markets for Breathe Right,” said McKenna. “I look forward to leading the CNS international business team in building on this foundation and capitalizing on the many growth opportunities outside the United States.”
McKenna earned an accounting degree from Temple University, Philadelphia. About CNS, Inc.
CNS, based in Minneapolis, is a growing company that designs and markets consumer health care products, including Breathe Right(R) nasal strips, Breathe Right Snore Relief(TM) throat spray, and the newly introduced Breathe Right Vapor Shot!(TM) personal vaporizer, as well as FiberChoice(R) chewable fiber tablets. The company focuses on products that address important consumer needs within the aging well/self-care market, including better breathing and digestive health. Its common stock is listed on the Nasdaq National Market under the ticker symbol “CNXS.” More information about CNS and its products is available at http://www.cns.com/ .
CNS, Inc.
CONTACT: Sam Reinkensmeyer, Chief Financial Officer of CNS, Inc.,+1-952-229-1500, sreinkensmeyer@cns.com ; Shawn Brumbaugh,sbrumbaugh@psbpr.com , or Marian Briggs, mbriggs@psbpr.com , both of PadillaSpeer Beardsley Inc., +1-612-455-1700
Web site: http://www.cns.com/
